0001104659-24-035724.txt : 20240318 0001104659-24-035724.hdr.sgml : 20240318 20240318200026 ACCESSION NUMBER: 0001104659-24-035724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240314 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Odysseas Kostas D CENTRAL INDEX KEY: 0001483080 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37544 FILM NUMBER: 24760707 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD STREET 2: 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 FORMER NAME: FORMER CONFORMED NAME: Kostas Odysseas D DATE OF NAME CHANGE: 20100202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5005 MCCONNELL AVE CITY: LOS ANGELES STATE: CA ZIP: 90066 BUSINESS PHONE: 310-665-2928 MAIL ADDRESS: STREET 1: 5005 MCCONNELL AVE CITY: LOS ANGELES STATE: CA ZIP: 90066 FORMER COMPANY: FORMER CONFORMED NAME: AmpliPhi Biosciences Corp DATE OF NAME CHANGE: 20130222 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 4 1 tm249071-5_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-14 0 0000921114 Armata Pharmaceuticals, Inc. ARMP 0001483080 Odysseas Kostas D 5005 MCCONNELL AVENUE LOS ANGELES CA 90066 1 0 0 0 0 Stock Options (Right to Buy) 3.38 2024-03-14 4 A 0 39666 0.00 A 2034-03-14 Common Stock 39666 39666 D Stock Options (Right to Buy) 3.38 2024-03-14 4 A 0 54343 0.00 A 2034-03-14 Common Stock 54343 94009 D The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024. The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date. /s/ Odysseas Kostas 2024-03-18